Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence

Archives of Otolaryngology - Head and Neck Surgery

Volumn 131, Issue 7, 2005, Pages 592-599

  Laccourreye, Ollivier ^a   Hans, Stéphane ^a   Ménard, Madeleine ^a   Garcia, Dominique ^a   Brasnu, Daniel ^a   Holsinger, F Christopher ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLASSIFICATION; CONTROLLED STUDY; EAR NOSE THROAT SURGERY; FEMALE; FOLLOW UP; HEALTH CENTER; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHARYNX CANCER; POSTOPERATIVE CARE; PREOPERATIVE RADIOTHERAPY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOFT PALATE; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TONSIL CARCINOMA; TRANSORAL LATERAL OROPHARYNGECTOMY; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; OROPHARYNX; OTORHINOLARYNGOLOGIC SURGICAL PROCEDURES; TONSILLAR NEOPLASMS;

EID: 23044464674     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.131.7.592     Document Type: Article

References (32)

1. Huet P-C. L'électro-coagulation dans le épithéliomas de l'amygdale-palatine. Ann Otolaryngol Chir Cervicofac. 1951;68:433-442.
2. Laccourreye H, André P, Haguet JF, Frachet B. La chirurgie de rattrapage dans les épitheliomas de l'amygdale. Ann Otolaryngol Chir Cervicofac. 1977;94:461-475.
3. Laccourreye H, Brasnu D, Beutter P, Cambournac Y, Candau P, Bre M. La place de la chirurgie première dans le traitement des épitheliomas de la région amygdalienne. Ann Otolaryngol Chir Cervicofac. 1981;98:491-496.
4. Cachin Y, Laccourreye H, Pinel J, et al. Proceedings of the Société Française d'Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale: epithéliomas de la région amygdalienne: indications thérapeutiques, résultats. Paris, France: Librairie Arnette; 1983.
5. Holsinger FC, McWhorter AJ, Ménard M, Garcia D, Laccourreye O. Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region, I: technique, complications, and functional results. Arch Otolaryngol Head Neck Surg. 2005;131:583-591.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
7. Fleming ID, Cooper JS, Henson DE, et al. Manual for Staging of Cancer/American Joint Committee on Cancer. 5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1997.
8. Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002;128:751-758.
9. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Garrett PG, Beale FA, Cummings BJ, et al. Cancer of the tonsil: results of radical radiation therapy with surgery in reserve. Am J Surg. 1983;146:432-435.
12. Lusinchi A, Wibault P, Marandas P, Kunkler I, Eschwege F. Exclusive radiation therapy: the treatment of early tonsillar tumors. Int J Radiat Oncol Biol Phys. 1989;17:273-277.
13. Wong CS, Ang KK, Fletcher GH, et al. Definitive radiotherapy for squamous cell carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1989;16:657-662.
14. Moose BD, Kelly MD, Levine PA, Constable WC, Cantrell RW, Larner JM. Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil. Head Neck. 1995;17:334-338.
15. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys. 1996;34:289-296.
16. Gwozdz JT, Morrison WH, Garden AS, Weber RS, Peters LJ, Ang KK. Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys. 1997;39:127-135.
17. Jackson SM, Hay JH, Flores AD, et al. Cancer of the tonsil: the results of ipsilateral radiation treatment. Radiother Oncol. 1999;51:123-128.
18. Mendenhall WM, Amdur RJ, Stringer SP, Villaret DB, Cassisi NJ. Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? J Clin Oncol. 2000;18:2219-2225.
19. Larson DL, Lindberg RD, Lane E, Goepfert H. Major complications of radiotherapy in cancer of the oral cavity and oropharynx: a 10-year retrospective study. Am J Surg. 1983;146:531-536.
20. Galati LT, Myers EN, Johnson JT. Primary surgery as treatment for early squamous cell carcinoma of the tonsil. Head Neck. 2000;22:294-296.
21. Watkinson JC, Owen C, Thompson S, Das Gupta AR, Glaholm J. Conservation surgery in the management of T1 and T2 oropharyngeal squamous cell carcinoma: the Birmingham UK experience. Clin Otolaryngol. 2002;27:541-548.
22. Vokes EE, Stenson K, Rosen FR, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol. 2003;21:320-326.
23. Calvert AH. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol. 1989;7:1748-1756.
24. Shin DM, Glisson BS, Khuri FR, et al. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002;95:322-330.
25. Kies MS, Bennett CL, Vokes EE. Locally advanced head and neck cancer. Curr Treat Options Oncol. 2001;2:7-13.
26. Pignon JP, Bourhis J, Domenge C, Designe L; MACH-NC Collaborative Group (Meta-Analysis of Chemotherapy on Head and Neck Cancer). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
27. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med. 2001;345:1890-1900.
28. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989;17:691-694.
29. Vaamonde P, Martin C, del Rio M, LaBella T. Second primary malignancies in patients with cancer of the head and neck. Otolaryngol Head Neck Surg. 2003;129:65-70.
30. Parsons JT, Mendenhall WM, Stringer SP, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer. 2002;94:2967-2980.
31. Laccourreye O, Brasnu D, Bassot V, Menard M, Khayat D, Laccourreye H. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results. J Clin Oncol. 1996;14:2331-2336.
32. Laccourreye O, Veivers D, Hans S, Menard M, Brasnu D, Laccourreye H. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer. 2001;92:1504-1511.